Dr. John Christopher Lynam , DO
Urology • Valparaiso, IN
85 E Us Highway 6 Ste 230
Valparaiso, IN 463838948
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on February 16, 2009; this date does not establish years in practice.
-
Published CMS data list 11,016 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- Q9967 — Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml: 3,026 service units.
- G2211 — Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's: 1,508 service units.
- 81003 — Automated urinalysis test: 1,447 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 30 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,205 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 312 prescription fills, including refills.
- Gemtesa (Vibegron) — 184 prescription fills, including refills.
- Finasteride — 138 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 21 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Urology in Indiana (2024, 207 clinicians with data). Median for this group: 1,656. Middle half: 469 to 3,233.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 4,244 in 2020 to 11,016 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
85 E Us Highway 6 Ste 230
Valparaiso, IN 463838948
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 2 distinct additional practice-address records in Portage, IN; Valparaiso, IN. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 1 group name: Advanced Urology Institute Llc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
2005
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
1,094 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $401,003 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $305,188 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
2,487 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$1,387,573 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $6,245.02 across 65 records.
By nature of payment (3 largest of 4)
- Consulting Fee: $3,764.00 across 1 record.
- Food and Beverage: $2,149.19 across 60 records.
- Education: $262.95 across 3 records.
Reporting-company totals (3 largest of 17)
- Ferring Pharmaceuticals Inc.: $4,389.25 across 15 records.
- Medtronic, Inc.: $453.35 across 6 records.
- Bayer Healthcare Pharmaceuticals Inc.: $273.12 across 9 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
21 years (graduated 2005)
CMS Doctors and Clinicians data list 2005 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2009
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Lynam has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Lynam as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Valparaiso and Indiana
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Urology in Indiana (2024, 207 clinicians with data). Median for this group: 1,656. Middle half: 469 to 3,233.
Too few clinicians listed under Urology in Valparaiso have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 85% of clinicians listed under Urology in Indiana (2024, 207 clinicians with data). Median for this group: $127,215. Middle half: $50,004 to $222,385.
Too few clinicians listed under Urology in Valparaiso have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 85% of clinicians listed under Urology in Indiana (2024, 207 clinicians with data). Median for this group: $90,868. Middle half: $37,737 to $162,559.
Too few clinicians listed under Urology in Valparaiso have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
Close to the middle for clinicians listed under Urology in Indiana (2024, 230 clinicians with data). Median for this group: 1,184. Middle half: 363 to 2,109.
Too few clinicians listed under Urology in Valparaiso have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Urology in Indiana (2024, 230 clinicians with data). Median for this group: $103,427. Middle half: $22,478 to $269,302.
Too few clinicians listed under Urology in Valparaiso have Medicare Part D data for 2024 to compare.
3 active clinicians are listed under Urology with a practice address in Valparaiso, IN (308 in Indiana).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 160% from 4,244 in 2020 to 11,016 in 2024.
- 2020: 4,244
- 2021: 6,202
- 2022: 7,332
- 2023: 5,311
- 2024: 11,016
-
Medicare-allowed amount
Medicare-allowed amount increased 82% from $220,082 in 2020 to $401,003 in 2024.
- 2020: $220,082
- 2021: $269,755
- 2022: $331,815
- 2023: $179,576
- 2024: $401,003
-
Paid by Medicare
Paid by Medicare increased 86% from $164,379 in 2020 to $305,188 in 2024.
- 2020: $164,379
- 2021: $206,067
- 2022: $250,130
- 2023: $141,938
- 2024: $305,188
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 42% from 2,089 in 2020 to 1,205 in 2024.
- 2020: 2,089
- 2021: 2,309
- 2022: 2,091
- 2023: 972
- 2024: 1,205
-
30-day fills
30-day fills decreased 49% from 4,900 in 2020 to 2,487 in 2024.
- 2020: 4,900
- 2021: 5,292
- 2022: 5,158
- 2023: 2,466
- 2024: 2,487
-
Part D drug cost
Part D drug cost increased 614% from $194,352 in 2020 to $1,387,573 in 2024.
- 2020: $194,352
- 2021: $207,851
- 2022: $190,121
- 2023: $98,812
- 2024: $1,387,573
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $214.79 in 2021 to $6,245.02 in 2025.
- 2021: $214.79
- 2022: $672.22
- 2023: $1,047.04
- 2024: $1,482.22
- 2025: $6,245.02
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 65 records totaling $6,245.02.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Ferring Pharmaceuticals Inc. |
Consulting Fee
Cash or cash equivalent
|
ADSTILADRIN | General | $3,764.00 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $160.04 |
| Medtronic, Inc. |
Food and Beverage
In-kind items and services
|
INTERSTIM | General | $146.49 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $118.29 |
| Medtronic, Inc. |
Food and Beverage
In-kind items and services
|
INTERSTIM | General | $110.99 |
| Telix Pharmaceuticals |
Food and Beverage
In-kind items and services
|
ILLUCCIX | General | $103.50 |
| Janssen Pharmaceuticals, Inc |
Education
In-kind items and services
|
ERLEADA | General | $99.99 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $99.44 |
| Telix Pharmaceuticals |
Food and Beverage
In-kind items and services
|
ILLUCCIX | General | $99.43 |
| Pfizer Inc. |
Education
In-kind items and services
|
— | General | $84.99 |
| Astellas Pharma US Inc |
Education
In-kind items and services
|
— | General | $77.97 |
| Medtronic, Inc. |
Food and Beverage
In-kind items and services
|
INTERSTIM | General | $74.09 |
| Ferring Pharmaceuticals Inc. |
Travel and Lodging
In-kind items and services
|
ADSTILADRIN | General | $68.88 |
| Medtronic, Inc. |
Food and Beverage
In-kind items and services
|
INTERSTIM | General | $48.16 |
| Medtronic, Inc. |
Food and Beverage
In-kind items and services
|
INTERSTIM | General | $42.08 |
| Telix Pharmaceuticals |
Food and Beverage
In-kind items and services
|
ILLUCCIX | General | $36.75 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $33.94 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $33.55 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $32.84 |
| Medtronic, Inc. |
Food and Beverage
In-kind items and services
|
INTERSTIM | General | $31.54 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $30.43 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $30.43 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $30.43 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $30.43 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $30.43 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
Q9967
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
|
3,026 | 42 | $1.00 | $0.13 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
1,508 | 902 | $38.25 | $16.20 |
|
81003
Automated urinalysis test
|
1,447 | 879 | $5.00 | $2.19 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
1,125 | 670 | $316.01 | $125.82 |
|
J1952
Leuprolide injectable, camcevi, 1 mg
|
840 | 15 | $137.38 | $56.81 |
|
36415
Insertion of needle into vein for collection of blood sample
|
534 | 372 | $11.06 | $7.02 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
457 | 385 | $26.50 | $10.70 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
414 | 360 | $215.36 | $88.89 |
|
A9579
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml
|
390 | 21 | $3.63 | $1.48 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
271 | 271 | $418.01 | $163.84 |
|
99490
Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
|
264 | 79 | $154.14 | $61.64 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
136 | 125 | $479.16 | $79.09 |
|
99439
Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month
|
75 | 40 | $117.32 | $47.02 |
|
74018
X-ray of abdomen, 1 view
|
66 | 46 | $65.64 | $28.55 |
|
76872
Ultrasound scan of pelvic region through rectum
|
54 | 53 | $134.81 | $31.46 |
|
55700
Biopsy of prostate gland
|
51 | 51 | $544.96 | $127.37 |
|
74178
Ct scan of abdomen and pelvis before and after contrast
|
43 | 42 | $616.88 | $230.34 |
|
72195
Mri scan of pelvis without contrast
|
39 | 19 | $328.90 | $115.02 |
|
72197
Mri scan of pelvis before and after contrast
|
38 | 20 | $484.76 | $170.49 |
|
51702
Simple insertion of temporary bladder tube
|
36 | 19 | $153.28 | $60.03 |
|
76770
Complete ultrasound scan behind abdominal cavity
|
34 | 30 | $233.06 | $103.09 |
|
96402
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
|
26 | 19 | $82.15 | $33.65 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
26 | 26 | $278.77 | $109.51 |
|
74176
Ct scan of abdomen and pelvis without contrast
|
20 | 20 | $280.80 | $111.40 |
|
51741
Electronic assessment of bladder emptying
|
18 | 18 | $36.00 | $7.89 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 312 | 26,550 | $4,990.10 | 138 |
| Gemtesa | Vibegron | 184 | 11,825 | $184,304.40 | 69 |
| Finasteride | Finasteride | 138 | 12,450 | $2,426.86 | 53 |
| Cephalexin | Cephalexin | 81 | 1,645 | $2,123.42 | 69 |
| Orgovyx | Relugolix | 76 | 2,270 | $198,939.80 | 20 |
| Myrbetriq | Mirabegron | 62 | 4,200 | $61,324.29 | 34 |
| Xtandi | Enzalutamide | 44 | 1,320 | $609,997.01 | — |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 37 | 226 | $200.28 | 33 |
| Silodosin | Silodosin | 33 | 2,256 | $2,410.08 | 12 |
| Levofloxacin | Levofloxacin | 25 | 129 | $90.08 | 23 |
| Methenamine Hippurate | Methenamine Hippurate | 25 | 2,025 | $2,689.62 | 15 |
| Nubeqa | Darolutamide | 25 | 750 | $315,769.22 | — |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 24 | 164 | $60.23 | 22 |
| Amoxicillin | Amoxicillin | 21 | 137 | $51.00 | 19 |
| Doxycycline Hyclate | Doxycycline Hyclate | 21 | 464 | $322.06 | 18 |
| Bicalutamide | Bicalutamide | 20 | 552 | $329.06 | 17 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 19 | 731 | $452.11 | 13 |
| Sildenafil Citrate | Sildenafil Citrate | 18 | 720 | $149.92 | — |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 15 | 347 | $291.30 | 15 |
| Trospium Chloride | Trospium Chloride | 13 | 450 | $586.04 | 13 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 12 | 77 | $66.01 | 12 |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2020-09-29NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20230123002874
FL
3577733039
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Advanced Urology Institute Llc
12109 County Rd, Oxford, FL 344842951
Phone: 3527023882
Secondary Practice Locations
85 E Us Highway 6
Valparaiso, IN 463838947
Phone: 2199836230
3630 Willowcreek Rd Ste 4
Portage, IN 463685075
Phone: 2192637700
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Urology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 85 E US HIGHWAY 6 STE 230, VALPARAISO, IN 463838948 (Tel: 2199836230)
Registered at 2022 KELLE DR, CHESTERTON, IN 463048708 (Tel: 2193643616)
Additional practice office at 85 E US Highway 6, Valparaiso, IN 463838947
Additional practice office at 3630 Willowcreek Rd Ste 4, Portage, IN 463685075
NPI status registered as active in NPPES database
Registered at 85 E US HIGHWAY 6, SUITE 230, VALPARAISO, IN 463838947 (Tel: 2199836230)
Registered at 85 E US HIGHWAY 6, SUITE 230, VALPARAISO, IN 463838947 (Tel: 2199836230)
Recorded as JOHN LYNAM, D.O.
Urology (license number reported to NPPES: IN 02003902A)
NPI status registered as active in NPPES database
Registered at 85 E US HIGHWAY 6, SUITE 230, VALPARAISO, IN 463838947 (Tel: 2199836230)
Registered at 85 E US HIGHWAY 6, SUITE 230, VALPARAISO, IN 463838947 (Tel: 2199836230)
Recorded as JOHN LYNAM, D.O.
Urology (license number reported to NPPES: IN 02003902A)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Urology Specialists in Valparaiso
Healthcare providers in ValparaisoMailing Address
2022 Kelle Dr
Chesterton, IN 463048708
Phone: 2193643616